Bachem Holding AG
SIX:BANB

Watchlist Manager
Bachem Holding AG Logo
Bachem Holding AG
SIX:BANB
Watchlist
Price: 67.8 CHF 0.59%
Market Cap: 5.1B CHF
Have any thoughts about
Bachem Holding AG?
Write Note

Bachem Holding AG
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Bachem Holding AG
Additional Paid In Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
Bachem Holding AG
SIX:BANB
Additional Paid In Capital
CHf632.9m
CAGR 3-Years
159%
CAGR 5-Years
52%
CAGR 10-Years
31%
Siegfried Holding AG
SIX:SFZN
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Lonza Group AG
SIX:LONN
Additional Paid In Capital
CHf2.5B
CAGR 3-Years
-3%
CAGR 5-Years
-6%
CAGR 10-Years
23%
Tecan Group AG
SIX:TECN
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
PolyPeptide Group AG
SIX:PPGN
Additional Paid In Capital
€203.1m
CAGR 3-Years
343%
CAGR 5-Years
154%
CAGR 10-Years
N/A
SKAN Group AG
SIX:SKAN
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Bachem Holding AG
Glance View

Market Cap
5.1B CHF
Industry
Life Sciences Tools & Services

Bachem Holding AG engages in the provision of peptides and oligonucleotides. The company is headquartered in Bubendorf, Basel-Landschaft and currently employs 1,639 full-time employees. The company went IPO on 2001-06-29. The firm focuses on the process development and manufacturing of peptides and organic molecules as active pharmaceutical ingredients (APIs), as well as on the development of biochemical products for research purposes. Its product portfolio comprises fluorescent dyes for the fluorescence energy transfer (FRET) analysis of receptor-ligand interactions, protein-protein interactions and the cleavage of substrate molecules, as well as glycosylated peptides for the manipulation of drug properties. The firm markets products under the Bachem and Clinalfa brands and operates production facilities in Switzerland and in the United States.

BANB Intrinsic Value
91.5 CHF
Undervaluation 26%
Intrinsic Value
Price

See Also

What is Bachem Holding AG's Additional Paid In Capital?
Additional Paid In Capital
632.9m CHF

Based on the financial report for Jun 30, 2024, Bachem Holding AG's Additional Paid In Capital amounts to 632.9m CHF.

What is Bachem Holding AG's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
31%

Over the last year, the Additional Paid In Capital growth was -4%. The average annual Additional Paid In Capital growth rates for Bachem Holding AG have been 159% over the past three years , 52% over the past five years , and 31% over the past ten years .

Back to Top